Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Steven Schopler

Orthopaedic Surgery of the Spine Van Nuys, CA Medical Doctor

NPI 1417988791 CMS profile 18609

6815 Noble Ave, Van Nuys, CA 91405

Open in the dashboard

General payments

$18,965

36 records reported · program years 2019–2024

Research payments

$21,900

Paid to them · 1 record reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$695 paid to institutions, not to them · program year 2021

Through program year 2024, Steven Schopler of Van Nuys, CA is reported in the CMS Open Payments database as having received $18,965 across 36 general payments and $21,900 in research payments paid to them. Separately, studies naming them as principal investigator received $695 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 67th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $1,910 3
2023 General $7,113 2
2022 General $44 1
2021 General $523 4
2020 General $7,038 9
2020 Research $21,900 1
2019 General $2,336 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Schopler
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Steven Schopler were reported at $0. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Steven Schopler Orthopaedic Surgery of the Spine median Middle half National median
2019 $2,336 $2,106 $337–$18,608 $163
2020 $7,038 $1,213 $156–$15,082 $114
2021 $523 $1,834 $271–$15,617 $132
2022 $44 $2,015 $320–$17,036 $149
2023 $7,113 $1,925 $336–$14,599 $160
2024 $1,910 $2,110 $341–$12,483 $164
2025 $0 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Organogenesis Inc. $7,089 8 payments
  2. Arthrex, Inc. $6,904 2 payments
  3. Globus Medical, Inc. $3,708 17 payments
  4. Alphatec Spine, Inc $807 2 payments
  5. RTI Surgical, Inc. $219 2 payments
  6. Amgen Inc. $148 2 payments
  7. Sanara MedTech Inc. $44 1 payment
  8. Titan Spine, LLC $28 1 payment
  9. Sanofi-Aventis U.S. LLC $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $14,513 6 payments
  2. Travel and Lodging $3,277 11 payments
  3. Food and Beverage $957 17 payments
  4. Royalty or License $219 2 payments
Products named General payments · program years 2019–2024
  1. Apligraf $6,336 3 payments
  2. Dermagraft $6,336 3 payments
  3. Puraply/Affinity/NuTech $6,336 3 payments
  4. RISE Spine/Spine Surgery $1,150 2 payments
  5. ELSA $1,150 2 payments
  6. Excelsius - GPS $1,009 4 payments
  7. Other - Miscellaneous $807 2 payments
  8. Puraply, NuShield, Affinity $700 4 payments
  9. RISE Spine $591 4 payments
  10. QUARTEX $494 3 payments
  11. Other $996 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Globus Medical, Inc. $21,900 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

15

Median for Orthopedic Surgery: 203

Drug cost

$22

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 15 $22

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 12 billing codes

Paid by Medicare

$11,855

Medicare's payments for the services billed

Medicare patients

122

Average age 75

Services billed

190

73 women, 49 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 72%
Ischemic heart disease 43%
Diabetes 26%
Chronic kidney disease 19%
Osteoporosis 17%
COPD 15%
Atrial fibrillation 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

37 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record